TRAF6 inhibits Th17 differentiation and TGF-β-mediated suppression of IL-2

59Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Transforming growth factor-β (TGF-β) has an essential role in the generation of inducible regulatory T (iTreg) and T helper 17 (Th17) cells. However, little is known about the TGF-β-triggered pathways that drive the early differentiation of these cell populations. Here, we report that CD4 + T cells lacking the molecular adaptor tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) exhibit a specific increase in Th17 differentiation in vivo and in vitro. We show that TRAF6 deficiency renders T cells more sensitive to TGF-β-induced Smad2/3 activation and proliferation arrest. Consistent with this, in TRAF6-deficient T cells, TGF-β more effectively down-regulates interleukin-2 (IL-2), a known inhibitor of Th17 differentiation. Remarkably, TRAF6-deficient cells generate normal numbers of Foxp3-expressing cells in iTreg differentiation conditions where exogenous IL-2 is supplied. These findings show an unexpected role for the adaptor molecule TRAF6 in Smad-mediated TGF-β signaling and Th17 differentiation. Importantly, the data also suggest that a main function of TGF-β in early Th17 differentiation may be the inhibition of autocrine and paracrine IL-2-mediated suppression of Th17 cell generation. © 2010 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Cejas, P. J., Walsh, M. C., Pearce, E. L., Han, D., Harms, G. M., Artis, D., … Choi, Y. (2010). TRAF6 inhibits Th17 differentiation and TGF-β-mediated suppression of IL-2. Blood, 115(23), 4750–4757. https://doi.org/10.1182/blood-2009-09-242768

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free